Annual report pursuant to Section 13 and 15(d)

Restatement of Financial Statements (Tables)

v3.22.2
Restatement of Financial Statements (Tables)
12 Months Ended
Dec. 31, 2021
Restatement of Financial Statements  
Summary of restatement on balance sheet, statement of operations and comprehensive loss, shareholders' equity, statement of cash flows

Balance sheet as of December 31, 2020

    

As of December 31, 2020

As Previously

2020 Restatement

Balance Sheet

    

Reported

    

Adjustment

    

As Restated

Total Current Assets

$

1,726,221

$

1,726,221

Property and Equipment, Net

 

30,566

 

 

30,566

Restricted cash

 

45,000

 

 

45,000

Goodwill

 

3,484,607

$

146,605

 

3,631,212

Intangible Assets and In-process R&D, Net

 

9,730,164

 

 

9,730,164

Operating Leases Assets with Right-of-Use

 

83,928

 

 

83,928

Other Assets

 

57,073

 

 

57,073

Total assets

 

$

15,157,559

 

146,605

 

$

15,304,164

Liabilities and stockholders’ equity

 

  

 

  

 

  

Total current liabilities

 

$

1,772,327

 

212,281

 

$

1,984,608

Contingent Consideration

 

5,342,950

 

(2,795,876)

 

2,547,074

Deferred Tax Liability

 

728,926

 

 

728,926

Paycheck Protection Program Loan

 

278,190

 

 

278,190

Non-current Operating Lease Liabilities

 

35,625

 

 

35,625

Total Non-Current Liabilities

 

6,385,691

 

(2,795,876)

 

3,589,815

Total liabilities

 

8,158,018

(2,583,595)

 

5,574,423

Stockholders’ equity

 

  

 

  

 

  

Preferred Stock, $0.01 par value

 

41

 

 

41

Common Stock, $0.01 par value

 

55,564

 

 

55,564

Additional paid-in-capital

 

115,283,572

 

1,500,030

 

116,783,602

Accumulated deficit

 

(108,338,834)

 

1,230,170

 

(107,108,664)

Accumulated Other Comprehensive Income

 

(802)

 

 

(802)

Total stockholders’ equity

 

6,999,541

 

2,730,200

 

9,729,741

Total liabilities and stockholders’ equity

 

$

15,157,559

$

146,605

 

$

15,304,164

Statement of Operations and Comprehensive Income for the year ended December 31, 2020

    

For the year ended December 31, 2020

As Previously

2020 Restatement

Statement of Operations and Comprehensive Loss

    

Reported

    

Adjustment

    

As restated

Collaboration Revenue

 

$

12,059

 

$

12,059

Research and Development

 

3,566,045

 

3,566,045

General and Administrative

 

4,658,769

 

4,658,769

Change in Fair Value of Contingent Consideration

 

$

(1,230,170)

 

(1,230,170)

Gain on Disposal of Foreign Entity

 

(113,717)

 

(113,717)

Total Operating Expenses

 

8,224,814

 

(1,343,887)

 

6,880,927

Operating Loss before Other Income

 

(8,212,755)

 

1,343,887

 

(6,868,868)

Other Income, net:

 

  

 

  

 

  

Gain on Disposal of Foreign Entity

 

113,717

 

(113,717)

 

Interest Income

 

23,339

 

 

23,339

Interest Expense

 

(4,186)

 

 

(4,186)

Total other (expense) income

 

132,870

 

(113,717)

 

19,153

Loss before Income Tax Benefit (Expense)

 

(8,079,885)

 

1,230,170

 

(6,849,715)

Income Tax Benefit (Expense)

 

(12,055)

 

 

(12,055)

Net loss

 

$

(8,091,940)

 

$

1,230,170

 

$

(6,861,770)

Weighted Average Shares Outstanding - Basic and Diluted

 

4,576,058

15,433

 

4,591,491

Basic and Diluted net loss per share

$

(1.77)

$

(1.49)

Other comprehensive loss:

Net loss

(8,091,940)

$

1,230,170

(6,861,770)

Dissolution of Foreign Entity

(113,717)

(113,717)

Foreign Currency Translate Adjustments

(26,550)

(26,550)

Comprehensive loss

 

$

(8,232,207)

$

1,230,170

 

$

(7,002,037)

Stockholders’ Equity as of December 31, 2020

    

As of December 31, 2020

As Previously

2020 Restatement

Stockholders’ equity

    

Reported

    

Adjustment

    

As restated

Preferred Stock, $0.01 par value

 

$

41

 

 

$

41

Common Stock, $0.01 par value

 

55,564

 

 

55,564

Additional paid-in-capital

 

115,283,572

 

$

1,500,030

 

116,783,602

Accumulated deficit

 

(108,338,834)

 

1,230,170

 

(107,108,664)

Accumulated Other Comprehensive Income

 

(802)

 

 

(802)

Total stockholders’ equity

 

$

6,999,541

 

$

2,730,200

 

$

9,729,741

Statement of Cash flows for the year ended December 31, 2020

    

For the year ended December 31, 2020

As Previously

2020 Restatement

Statement of Cash Flows

    

Reported

    

Adjustment

    

As restated

Operating Activities

Net loss

 

$

(8,091,940)

 

$

1,230,170

 

$

(6,861,770)

Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities:

Depreciation and Amortization of Intangible Assets

 

33,399

 

 

33,399

Reduction of Right-of-Use Assets

 

166,822

 

 

166,822

Stock-Based Compensation

 

723,856

 

 

723,856

Change in Fair Value of Contingent Consideration

 

 

(1,230,170)

 

(1,230,170)

Expiration of a Prepaid Agreement

 

159,848

 

 

159,848

Deferred Taxes

 

12,055

 

 

12,055

Changes in Operating Assets and Liabilities, Net of Effects of Business Acquired:

 

  

 

 

  

Prepaid Expenses and Other Current Assets

 

(146,971)

 

 

(146,971)

Refundable Tax Credit Receivable

 

(18,957)

 

 

(18,957)

Other Assets

 

18,916

 

 

18,916

Accounts Payable

 

136,697

 

 

136,697

Lease Liabilities

 

(166,822)

 

 

(166,822)

Accrued Expenses

 

(144,072)

 

 

(144,072)

Net cash used in operating activities

 

(7,317,169)

 

 

(7,317,169)

Net cash used in investing activities

 

(244,438)

 

 

(244,438)

Net cash provided by financing activities

 

4,997,503

 

 

4,997,503

Effects of Exchange Rate Changes on Cash

 

(26,931)

 

 

(26,931)

Net Cash Increase or decrease

 

(2,591,035)

 

 

(2,591,035)

Cash, Including Restricted Cash, Beginning of Year

 

3,821,712

 

 

3,821,712

Cash, Including Restricted Cash, End of Year

 

$

1,230,677

 

 

$

1,230,677

Balance Sheet as of December 31, 2021

    

As of December 31, 2021

 

As Previously

2020 Restatement

2021 Restatement

 

Balance Sheet

    

Reported

    

Adjustment

    

Adjustment

    

As Restated

    

Total Current Assets

 

$

8,990,770

 

 

 

$

8,990,770

Property and Equipment, Net

 

73,999

 

 

 

73,999

Restricted cash

 

45,000

 

 

 

45,000

Goodwill

 

 

$

146,605

 

$

(146,605)

 

Intangible Assets and In-process R&D, Net

 

8,695,850

 

 

2,072,314

 

10,768,164

Operating Leases Assets with Right-of-Use

 

209,411

 

 

 

209,411

Other Assets

 

42,964

 

 

 

42,964

Total assets

 

$

18,057,994

 

$

146,605

 

$

1,925,709

 

$

20,130,308

Liabilities and stockholders’ equity

 

  

 

  

 

  

 

  

Total current liabilities

 

1,609,608

 

 

 

1,609,608

Contingent Consideration

 

6,518,770

 

(2,583,595)

 

(886,220)

 

3,048,955

Deferred Tax Liability

 

614,436

 

 

187,695

 

802,131

Non-current Operating Lease Liabilities

 

90,566

 

 

 

90,566

Total Non-Current Liabilities

 

7,223,772

 

(2,795,876)

 

(698,525)

 

3,941,652

Total liabilities

 

8,833,380

 

(2,583,595)

 

(698,525)

 

5,551,260

Stockholders’ equity

 

  

 

  

 

  

 

  

Preferred Stock, $0.01 par value

 

 

 

 

Common Stock, $0.01 par value

 

126,640

 

 

 

126,640

Additional paid-in-capital

 

133,918,158

 

1,500,030

 

 

135,418,188

Accumulated deficit

 

(124,733,753)

 

1,230,170

 

2,624,234

 

(120,879,349)

Accumulated Other Comprehensive Income

 

(86,431)

 

 

 

(86,431)

Total stockholders’ equity

 

9,224,614

 

2,730,200

 

2,624,234

 

14,579,048

Total liabilities and stockholders’ equity

 

$

18,057,994

 

$

146,605

 

$

1,925,709

 

$

20,130,308

Statement of Operations and Comprehensive Loss for the year ended December 31, 2021

    

For the year ended December 31, 2021

As Previously

2021 Restatement

Statement of Operations and Comprehensive Loss

    

Reported

    

Adjustment

    

As restated

Research and Development

 

$

5,350,264

 

 

$

5,350,264

General and Administrative

 

5,323,649

 

 

5,323,649

Goodwill Impairment

 

4,498,234

 

$

(460,423)

 

4,037,811

Intangible Asset Impairment

 

1,770,314

 

(1,770,314)

 

Change in Fair Value of Contingent Consideration

(475,956)

(475,956)

Total Operating Expenses

 

16,942,461

 

(2,706,693)

 

14,235,768

Operating Loss before Other Income

 

(16,942,461)

 

2,706,693

 

(14,235,768)

Other income, net:

 

  

 

  

 

  

Gain on Forgiveness of Loan

 

278,190

 

 

278,190

Change in Fair Value of Contingent Consideration

 

(29,719)

 

29,719

 

Interest Expense

(6,851)

(6,851)

Interest Income

 

1,141

 

 

1,141

Total other income

 

242,761

 

29,719

 

272,480

Loss before Income Tax Benefit (Expense)

 

(16,699,700)

 

2,736,412

 

(13,963,288)

Income Tax Benefit (Expense)

 

304,781

 

(112,178)

 

192,603

Net loss

 

$

(16,394,919)

 

$

2,624,234

 

$

(13,770,685)

Weighted Average Shares Outstanding - Basic and Diluted

 

9,240,500

 

403,461

 

9,643,961

Basic and Diluted net loss per share

 

$

(1.77)

 

 

$

(1.43)

Other comprehensive loss:

Net loss

(16,394,919)

$

2,624,234

(13,770,685)

Foreign Currency Translate Adjustments

(85,629)

(85,629)

Comprehensive loss

$

(16,480,548)

$

2,624,234

$

(13,856,314)

Stockholders’ Equity as of December 31, 2021

    

As of December 31, 2021

2020

2021

As Previously

Restatement

Restatement

Stockholders’ equity

    

Reported

    

Adjustment

    

Adjustment

    

As restated

Preferred Stock, $0.01 par value

 

 

 

 

Common Stock, $0.01 par value

 

$

126,640

 

 

 

$

126,640

Additional paid-in-capital

 

133,918,158

 

$

1,500,030

 

 

135,418,188

Accumulated deficit

 

(124,733,753)

 

1,230,170

 

$

2,624,234

 

(120,879,349)

Accumulated Other Comprehensive Income

 

(86,431)

 

 

 

(86,431)

Total stockholders’ equity

 

$

9,224,614

 

$

2,730,200

 

$

2,624,234

 

$

14,579,048

Statement of Cash Flows for the year ended December 31, 2021

    

For the year ended December 31, 2021

As Previously

2021 Restatement

Statement of Cash Flows

    

Reported

    

Adjustment

    

As restated

Operating Activities

Net loss

 

$

(16,394,919)

 

$

2,624,234

 

$

(13,770,685)

Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities:

Depreciation and Amortization of Intangible Assets

 

45,296

 

 

45,296

Reduction of Right-of-Use Assets

 

181,977

 

 

181,977

Stock-Based Compensation

 

842,475

 

 

842,475

Contingent Consideration

 

(212,281)

 

(293,394)

 

(505,675)

Deferred Taxes

 

(304,782)

 

112,179

 

(192,603)

Paycheck Protection Program Loan Forgiveness

 

(278,190)

 

 

(278,190)

Goodwill Impairment Loss

 

4,498,234

 

(460,423)

 

4,037,811

Intangible Asset Impairment Loss

 

1,770,314

 

(1,770,314)

 

Changes in Operating Assets and Liabilities, Net of Effects of Business Acquired:

 

  

 

 

  

Prepaid Expenses and Other Current Assets

 

(156,951)

 

 

(156,951)

Refundable Tax Credit Receivable

 

(441,196)

 

 

(441,196)

Other Assets

 

14,111

 

 

14,111

Accounts Payable

 

(310,665)

 

 

(310,665)

Lease Liabilities

 

(181,977)

 

 

(181,977)

Accrued Expenses

 

40,882

 

 

40,882

Net cash used in operating activities

 

(10,887,672)

 

212,282

 

(10,675,390)

Net cash used in investing activities

 

(157,020)

 

 

(157,020)

Financing Activities

Proceeds stock offerings

18,750,016

18,750,016

Stock Issuance costs

(1,004,809)

(1,004,809)

Exercise Warrants

50,001

50,001

Repayment of Loan Payable

(212,282)

(212,282)

Net cash provided by financing activities

 

17,795,208

 

(212,282)

 

17,582,926

Effects of Exchange Rate Changes on Cash

 

(81,503)

 

 

(81,503)

Net Cash Increase or decrease

 

6,669,013

 

 

6,669,013

Cash, Including Restricted Cash, Beginning of Year

 

1,230,677

 

 

1,230,677

Cash, Including Restricted Cash, End of Year

 

$

7,899,690

 

 

$

7,899,690